Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

26.50 +0.20 (+0.75%)
Streaming Delayed Price Updated: 2:37 PM EST, Jan 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 18,784,163
Open 26.45
Bid (Size) 26.49 (186)
Ask (Size) 26.50 (79)
Prev. Close 26.30
Today's Range 26.39 - 26.64
52wk Range 24.48 - 31.54
Shares Outstanding 5,606,688,356
Dividend Yield 6.34%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pfizer Unusual Options Activity For January 21
Via Benzinga
Got $500? 2 Pharmaceutical Stocks to Buy and Hold Forever
Via The Motley Fool

Performance

YTD
-0.43%
-0.43%
1 Month
-0.80%
-0.80%
3 Month
-8.41%
-8.41%
6 Month
-10.49%
-10.49%
1 Year
-6.41%
-6.41%

More News

Read More
Healthcare And Biotech Stocks Lag The Market Again
Via Talk Markets
Topics Stocks / Equities
3 Subtle Investing Mistakes I Won't Repeat in 2025 And Beyond
Via The Motley Fool
Investing $10,000 in Each of These 5 Ultra-High-Yield Dividend Stocks Could Generate Over $3,000 in Passive Income in 2025
Via The Motley Fool
The Smartest Dividend Stocks to Buy With $100 Right Now
Via The Motley Fool
A Closer Look at Pfizer's Options Market Dynamics
Via Benzinga
3 High-Yield Dividend ETFs to Buy to Generate Passive Income
Via The Motley Fool
Topics ETFs
Why I Just Bought These 3 Ultra-High-Yield Dividend Stocks
Via The Motley Fool
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
Via Benzinga
Topics Economy
Exposures Interest Rates
Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks
Via Investor's Business Daily
Topics Government
Exposures Political
Qorvo Soars 7% After Hours As Activist Investor Starboard Reportedly Takes Stake In Semiconductor Company
Via Benzinga
Got $200? 2 Dividend Stocks to Buy and Hold Forever
Via The Motley Fool
Pfizer Eyes $20 Billion Revenue From Acquisitions Amid Patent Cliff Challenges
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Clinical Research Firm ICON Faces Headwinds From Top Customers And Biotech Recovery Uncertainty
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell?
Via Investor's Business Daily
3 High-Yield Dividend Stocks to Buy in 2025
Via The Motley Fool
Investing $5,000 Just Once in These 3 Ultra-High-Yielding Stocks Could Earn You $320 in Passive Income Every Year
Via The Motley Fool
BioNTech Positioned For Solid Growth Amid Oncology Transition: Analyst
Via Benzinga
Pfizer Reveals Encouraging Data From Pivotal Bladder Cancer Trial
Via Benzinga
Pfizer Is 'Too Low To Sell,' Jim Cramer Says: Recommends Nvidia For Robotics Exposure
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Unstoppable Yields: 3 Blue-Chip Stocks to Maximize Returns
Via MarketBeat
Topics Stocks
Exposures US Equities
Pfizer’s Sasanlimab in Combination with BCG Improves Event-Free Survival in Patients with BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer
From Pfizer Inc.
Via Business Wire
Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.